|
13.12.2024 13:55:44
|
Inovio Pharmaceuticals Prices $30 Mln Public Offering With Warrants
(RTTNews) - Inovio Pharmaceuticals, Inc. (INO), a clinical-stage biotechnology company, Friday announced the pricing of a public offering of 10 million common shares and also warrants to buy 10 million shares.
The offering is expected to bring in $30 million before subtracting underwriting fees, commissions, and other expenses, and without factoring in any warrant exercises. All of the securities in the offering are being sold by INOVIO.
Each warrant allows the purchase of a share at an exercisable price of $3.76. The combined public offering price for one share and one warrant is $3.00.The offering is expected to close on December 16.
Stephens Inc. is serving as the lead manager, while, Oppenheimer & Co. Inc. and Citizens JMP are serving as the joint book-running managers for the offering.
In the pre-market trade today, INO shares were trading down more than 23% or $0.87 at $2.89 on the Nasdaq.
Analysen zu Inovio Pharmaceuticals Inc
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
NEU✅ Wolters Kluwer
NEU✅ American Express
NEU✅ Deckers Outdoor
inklusive Rebalancing:
❌ Synopsys
❌ Vertex Pharmaceuticals Inc
❌ Targa Resources
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
US-Börsen schliessen wenig verändert -- SMI schlussendlich fester -- DAX letztlich im Minus -- Asiens Börsen schliessen uneinsDer heimische Aktienmarkt trat am Mittwoch auf der Stelle, während der deutsche Leitindex nachgab. Die US-Börsen präsentierten sich zur Wochenmitte wenig bewegt. In Asien fanden die Börsen am Mittwoch keine gemeinsame Richtung.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |